Clinical Trial Update: Use of Percutaneous Tibial Nerve Stimulation With Solifenacin or Placebo to Treat Refractory Overactive Bladder [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating solifenacin with percutaneous tibial nerve stimulation versus placebo for refractory overactive bladder was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Solifenacin (solifenacin)

Snippet

Sponsor: Bay State Clinical Trials, Inc. | Conditions: Overactive Bladder | Phase 4 | Status: TERMINATED